Immunomodulation and COVID-19: Is There a Winning Combination?

Coronavirus disease-2019 (COVID-19) has been testing the boundaries of science on several fronts. Pharmacotherapy has seen the highs of several drugs being tried as the best option as well as the lows of no drug proven to be effective. In this edition of the Indian Journal of Critical Care Medicine,...

Descripción completa

Detalles Bibliográficos
Autor principal: Samavedam, Srinivas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751030/
https://www.ncbi.nlm.nih.gov/pubmed/33384504
http://dx.doi.org/10.5005/jp-journals-10071-23691
Descripción
Sumario:Coronavirus disease-2019 (COVID-19) has been testing the boundaries of science on several fronts. Pharmacotherapy has seen the highs of several drugs being tried as the best option as well as the lows of no drug proven to be effective. In this edition of the Indian Journal of Critical Care Medicine, Mahale et al. retrospectively evaluated a combination of drugs targeted at immunomodulation. HOW TO CITE THIS ARTICLE: Samavedam S. Immunomodulation and COVID-19: Is There a Winning Combination? Indian J Crit Care Med 2020;24(11):1015–1017.

Ejemplares similares